Clicky

Inari Medical, Inc.(NARI)

Description: Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.


Keywords: Medicine Disease Catheter Hematology FDA Quality Of Life Thrombosis Angiology Veins Deep Vein Thrombosis Blood Clots Venous Thrombosis Pulmonary Embolism Thrombus Embolectomy Venous Diseases Venous Thromboembolism Thrombectomy

Home Page: www.inarimedical.com

NARI Technical Analysis

6001 Oak Canyon
Irvine, CA 92618
United States
Phone: 877 923 4747


Officers

Name Title
Mr. William H. Hoffman CEO, Pres & Director
Mr. Mitchell C. Hill Chief Financial Officer
Mr. Andrew J. Hykes Chief Operating Officer
Dr. Thomas M. Tu M.D. Chief Medical Officer
Ms. Janet Byk VP of Fin. & Accounting
Ms. Angela Ahmad Gen. Counsel & Sec.
Mr. Eric Khairy Sr. VP of Marketing
Mr. John R. Borrell Sr. VP of Sales
Ms. Dena Truelove VP of HR
Ms. Tara Dunn Sr. VP of Clinical Affairs & Market Devel.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 1428.5714
Trailing PE: 0
Price-to-Book MRQ: 8.943
Price-to-Sales TTM: 9.8391
IPO Date: 2020-05-22
Fiscal Year End: December
Full Time Employees: 800
Back to stocks